Latest News

Rapid-acting antidepressant for treatment-resistant depression: New insights

Researchers have generated fresh insights that could aid in the development of rapid-acting antidepressants for treatment-resistant depression. The researchers found that by blocking NMDA receptors with the drug ketamine, they could elicit rapid antidepressant effects in patients with treatment-resistant depression. Ketamine was developed as an anesthetic, but is better known publicly for its abuse as the party drug Special K. Researchers are now seeking alternatives because ketamine can produce side effects that include hallucinations and the potential for abuse -- limiting its utility as an antidepressant.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Head impacts, collegiate football practice, games

  • Scientists identify that memories can be lost and found

  • Even moderate picky eating can have negative effects on children's health

  • Marriage can lead to dramatic reduction in heavy drinking in young adults

  • Frequent travel is damaging to health and wellbeing, according to new study

  • Character traits outweigh material benefits in assessing value others bring to us

  • Our elegant brain: Motor learning in the fast lane

  • Brain teaser: 3-D printed 'tissue' to help combat disease

  • 'Brain training' app may improve memory, daily functioning of people with schizophrenia

  • New survey enhances precision of distinguishing between expectable vs. worrisome early childhood misbehavior

  •